Skip to content

Drrx stocktwits

HomeFlegel61415Drrx stocktwits
25.02.2021

DURECT Corporation Common Stock (DRRX) Pre-Market Quotes ... Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these DRRX DURECT Corporation Stock Quote - FINVIZ.com DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results PR Newswire +49.01% Apr-25-19 08:00AM DRRX Stock Price & Charts | Durect

DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results PR Newswire +49.01% Apr-25-19 08:00AM

11 May 2020 Durect (DRRX) delivered earnings and revenue surprises of -25.00% and -41.41 %, respectively, for the quarter ended March 2020. Do the  100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits DRRX · Durect Corp · Joice Judy R, SVP Operations, Corp QA, S - Sale+OE  We saw the resistance at $5.50 and new that was where to exit. On Stocktwits, a lot of traders are chasing $REKR looking for the next move. In all honesty, the  Durect Corp Total Return, Jun 8 '20, 360.5%. Johnson & Johnson Total Return, Jun 8 '20, 8.92%. Adverum Biotechnologies Inc Total Return, Jun 8 '20, 105.2%. Durect Corp Total Return, Jun 1 '20, 348.6%. Gilead Sciences Inc Total Return, Jun 1 '20, 25.41%. Prestige Consumer Healthcare Inc Total Return, Jun 1 '20  7/8, 128, -, 3.95 | 0.50, DURECT Corporation, DRRX, 2.34, -5.3, 2.17 - 2.79, 80765. Weak Bearish Trend. The closing price is above the upper limit of the 13-  

View the basic DRRX option chain and compare options of DURECT Corporation on Yahoo Finance.

FDA Nod For MRK's Antibiotic; DRRX Awaits Big Day In Dec ... DRRX closed Wednesday's trading at $0.69, up 0.83%. The FDA has given market clearance for FX 635 Laser system, developed by privately-held Erchonia Corporation, for chronic low back pain of

DRRX | Complete Durect Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

DURECT Corporation (DRRX) Interactive Stock Chart - Yahoo ... DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, President and CEO, will be presenting at the Jefferies 2020 Virtual Health Care Conference, Wednesday, June 3, 2020 at 10:00 Durect Corporation Stock Quote: DRRX Stock News, Quotes ... Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates Durect (DRRX) delivered earnings and revenue surprises of -25.00% and -41.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

DRRX on StockCharts.com DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. It focuses on the development of products for the treatment of various chronic and episodic disease areas, such as pain, central nervous system disorders, cardiovascular disease, and other chronic diseases.

DRRX - Stocktwits